Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

The chicken hypersensitive site-4 insulator cannot fully shield the murine phosphoglycerate kinase-1 promoter from integration site effects in transgenic mice.

Farzaneh F, Mirzapoor Z, Jahangirian E, Heidari F, Hashemi E, Rahim-Tayefeh A, Fatemi N, Jamshidizad A, Dashtizad M, Shamsara M.

3 Biotech. 2019 Jul;9(7):255. doi: 10.1007/s13205-019-1786-5. Epub 2019 Jun 7.

PMID:
31192080
2.

Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa.

Lwin SM, Syed F, Di WL, Kadiyirire T, Liu L, Guy A, Petrova A, Abdul-Wahab A, Reid F, Phillips R, Elstad M, Georgiadis C, Aristodemou S, Lovell PA, McMillan JR, Mee J, Miskinyte S, Titeux M, Ozoemena L, Pramanik R, Serrano S, Rowles R, Maurin C, Orrin E, Martinez-Queipo M, Rashidghamat E, Tziotzios C, Onoufriadis A, Chen M, Chan L, Farzaneh F, Del Rio M, Tolar J, Bauer JW, Larcher F, Antoniou MN, Hovnanian A, Thrasher AJ, Mellerio JE, Qasim W, McGrath JA.

JCI Insight. 2019 Jun 6;4(11). pii: 126243. doi: 10.1172/jci.insight.126243. eCollection 2019 Jun 6.

3.

Association of HOTAIR gene polymorphisms and haplotypes with uterine leiomyoma susceptibility in southeast of Iran.

Farzaneh F, Saravani M, Esmailpoor M, Mokhtari M, Teimoori B, Rezaei M, Salimi S.

Mol Biol Rep. 2019 May 22. doi: 10.1007/s11033-019-04881-w. [Epub ahead of print]

PMID:
31119441
4.

Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated Ex Vivo Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIA.

Ellison SM, Liao A, Wood S, Taylor J, Youshani AS, Rowlston S, Parker H, Armant M, Biffi A, Chan L, Farzaneh F, Wynn R, Jones SA, Heal P, Gaspar HB, Bigger BW.

Mol Ther Methods Clin Dev. 2019 Apr 6;13:399-413. doi: 10.1016/j.omtm.2019.04.001. eCollection 2019 Jun 14.

5.

Effect of apelin on cardiac contractility in acute reno-vascular hypertension: The role of apelin receptor and kappa opioid receptor heterodimerization.

Yeganeh-Hajahmadi M, Najafipour H, Farzaneh F, Esmaeili-Mahani S, Joukar S.

Iran J Basic Med Sci. 2018 Dec;21(12):1305-1315. doi: 10.22038/IJBMS.2018.31361.7555.

6.

Lentiviral Vector Purification Using Genetically Encoded Biotin Mimic in Packaging Cell.

Mekkaoui L, Parekh F, Kotsopoulou E, Darling D, Dickson G, Cheung GW, Chan L, MacLellan-Gibson K, Mattiuzzo G, Farzaneh F, Takeuchi Y, Pule M.

Mol Ther Methods Clin Dev. 2018 Oct 23;11:155-165. doi: 10.1016/j.omtm.2018.10.008. eCollection 2018 Dec 14.

7.

Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia

Hosseini MS, Khosravi D, Farzaneh F, Ebrahimi A, Arab M, Ashraf Ganjoie T, Jamdar F, Moridi A, Chehrazi M.

Asian Pac J Cancer Prev. 2018 Nov 29;19(11):3071-3075.

8.

IL-15/IL-15Rα/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice.

Shi Y, Dincheva-Vogel L, Ayemoba CE, Fung JP, Bergamaschi C, Pavlakis GN, Farzaneh F, Gaensler KML.

Blood Adv. 2018 Nov 27;2(22):3177-3192. doi: 10.1182/bloodadvances.2018019026.

9.

Identification of novel inhibitor against endonuclease subunit of Influenza pH1N1 polymerase: A combined molecular docking, molecular dynamics, MMPBSA, QMMM and ADME studies to combat influenza A viruses.

Mohseni SS, Nasri F, Davari K, Mirzaie S, Moradzadegan A, Abdi F, Farzaneh F.

Comput Biol Chem. 2018 Dec;77:279-290. doi: 10.1016/j.compbiolchem.2018.08.005. Epub 2018 Aug 23.

PMID:
30396155
10.

Assessment of occurrence of preeclampsia and some clinical and demographic risk factors in Zahedan city in 2017.

Farzaneh F, Tavakolikia Z, Soleimanzadeh Mousavi SH.

Clin Exp Hypertens. 2018 Nov 2:1-6. doi: 10.1080/10641963.2018.1523919. [Epub ahead of print]

PMID:
30388904
11.

Impact of Gestational Weight Gain on Cesarean Delivery Risk, Perinatal Birth Weight and Gestational Age in Women with Normal Pre-pregnancy BMI.

Omani-Samani R, Sepidarkish M, Safiri S, Esmailzadeh A, Vesali S, Farzaneh F, Almasi-Hashiani A.

J Obstet Gynaecol India. 2018 Aug;68(4):258-263. doi: 10.1007/s13224-017-1023-2. Epub 2017 Jun 15.

PMID:
30065539
12.

Model for Prediction of Optimal Debulking of Epithelial Ovarian Cancer

Arab M, Jamdar F, Sadat Hosseini M, Ghodssi- Ghasemabadi R, Farzaneh F, Ashrafganjoei T.

Asian Pac J Cancer Prev. 2018 May 26;19(5):1319-1324.

13.

Central Asia and East Europe Trial Group.

Gültekin M, Urmancheeva A, Stepanyan A, Kurdiani D, Farzaneh F, Motlagh AG, Kairbayev M, Kaidarova D, Aliyev S.

Int J Gynecol Cancer. 2018 May;28(4):848-849. doi: 10.1097/IGC.0000000000001231. No abstract available.

PMID:
29538250
14.

Contralateral Radiculopathy: A Kernohan-Woltman Notch-like Phenomenon.

Safdarian M, Farzaneh F, Rahimi-Movaghar V.

Asian J Neurosurg. 2018 Jan-Mar;13(1):165-167. doi: 10.4103/1793-5482.180954.

15.

Surgical management of a thoracic extradural arachnoid cyst with communication to subarachnoid space through nerve root: a case report.

Faghih Jouibari M, Rostami M, Farahbakhsh F, Farzaneh F, Khadivi M.

Br J Neurosurg. 2018 Feb 9:1-4. doi: 10.1080/02688697.2018.1436692. [Epub ahead of print]

PMID:
29424245
16.

Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing.

Jamdar F, Farzaneh F, Navidpour F, Younesi S, Balvayeh P, Hosseini M, Ghodssi-Ghasemabadi R.

Infect Agent Cancer. 2018 Jan 25;13:6. doi: 10.1186/s13027-018-0178-5. eCollection 2018.

17.

Comparison between performance of single-fiber reflectance spectroscopy (SFRS) system and colposcopy: a phase III trial.

Hariri Tabrizi S, Farzaneh F, Aghamiri SMR, Arab M, Hosseini M, Ashrafganjoei T, Chehrazi M.

Lasers Med Sci. 2017 Dec;32(9):2139-2144. doi: 10.1007/s10103-017-2353-0. Epub 2017 Oct 26.

PMID:
29075996
18.

Occupations and the Risk of Bladder Cancer in Yazd Province: A Case-Control Study.

Farzaneh F, Mehrparvar AH, Lotfi MH.

Int J Occup Environ Med. 2017 Oct;8(4):191-198. doi: 10.15171/ijoem.2017.1085.

19.

An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinoma.

Temam S, Spicer J, Farzaneh F, Soria JC, Oppenheim D, McGurk M, Hollebecque A, Sarini J, Hussain K, Soehrman Brossard S, Manenti L, Evers S, Delmar P, Di Scala L, Mancao C, Feuerhake F, Andries L, Ott MG, Passioukov A, Delord JP.

Ann Oncol. 2017 Nov 1;28(11):2827-2835. doi: 10.1093/annonc/mdx489.

20.

Retroviral insertional mutagenesis implicates E3 ubiquitin ligase RNF168 in the control of cell proliferation and survival.

Kizilors A, Pickard MR, Schulte CE, Yacqub-Usman K, McCarthy NJ, Gan SU, Darling D, Gäken J, Williams GT, Farzaneh F.

Biosci Rep. 2017 Jul 27. pii: BSR20170843. doi: 10.1042/BSR20170843. [Epub ahead of print]

21.
22.

Lack of HPV in Benign and Malignant Epithelial Ovarian Tumors in Iran

Farzaneh F, Nadji SA, Khosravi D, Hosseini MS, Hashemi Bahremani M, Chehrazi M, Bagheri G, Sigaroodi A, Haghighatian Z.

Asian Pac J Cancer Prev. 2017 May 1;18(5):1233-1236.

23.

Transactivator protein: An alternative for delivery of recombinant proteins for safer reprogramming of induced Pluripotent Stem Cell.

Nordin F, Ahmad RNR, Farzaneh F.

Virus Res. 2017 May 2;235:106-114. doi: 10.1016/j.virusres.2017.04.007. Epub 2017 Apr 10. Review.

PMID:
28408207
24.

Cancer Immunotherapy: Whence and Whither.

Stambrook PJ, Maher J, Farzaneh F.

Mol Cancer Res. 2017 Jun;15(6):635-650. doi: 10.1158/1541-7786.MCR-16-0427. Epub 2017 Mar 29. Review.

25.

Value of Sentinel Lymph Node (SLN) Mapping and Biopsy using Combined Intracervical Radiotracers and Blue Dye Injections for Endometrial Cancer

Farzaneh F, Moridi A, Azizmohammadi Z, Ansari J M, Hosseini MS, Arab M, Ashrafganjoei T, Mazaheri M.

Asian Pac J Cancer Prev. 2017 Feb 1;18(2):431-435.

26.

Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.

Nordin F, Hamid ZA, Chan L, Farzaneh F, Hamid MK.

Methods Mol Biol. 2016;1448:159-73. doi: 10.1007/978-1-4939-3753-0_12.

PMID:
27317180
27.

Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment.

Kordasti S, Costantini B, Seidl T, Perez Abellan P, Martinez Llordella M, McLornan D, Diggins KE, Kulasekararaj A, Benfatto C, Feng X, Smith A, Mian SA, Melchiotti R, de Rinaldis E, Ellis R, Petrov N, Povoleri GA, Chung SS, Thomas NS, Farzaneh F, Irish JM, Heck S, Young NS, Marsh JC, Mufti GJ.

Blood. 2016 Sep 1;128(9):1193-205. doi: 10.1182/blood-2016-03-703702. Epub 2016 Jun 8.

28.

Analysis of CYP17, CYP19 and CYP1A1 Gene Polymorphisms in Iranian Women with Breast Cancer.

Farzaneh F, Noghabaei G, Barouti E, Pouresmaili F, Jamshidi J, Fazeli A, Emamalizadeh B, Darvish H.

Asian Pac J Cancer Prev. 2016;17(S3):23-6.

29.

Investigating Preoperative Hematologic Markers for Prediction of Ovarian Cancer Surgical Outcome.

Ashrafganjoei T, Mohamadianamiri M, Farzaneh F, Hosseini MS, Arab M.

Asian Pac J Cancer Prev. 2016;17(3):1445-8.

30.

Cervical Cancer Screening: Recommendations for Muslim Societies.

Khodakarami N, Farzaneh F, Yavari P, Akbari ME.

Asian Pac J Cancer Prev. 2016;17(1):239-47.

31.

Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB.

Georgiadis C, Syed F, Petrova A, Abdul-Wahab A, Lwin SM, Farzaneh F, Chan L, Ghani S, Fleck RA, Glover L, McMillan JR, Chen M, Thrasher AJ, McGrath JA, Di WL, Qasim W.

J Invest Dermatol. 2016 Jan;136(1):284-92. doi: 10.1038/JID.2015.364.

32.

Lentiviral Engineered Fibroblasts Expressing Codon Optimized COL7A1 Restore Anchoring Fibrils in RDEB.

Georgiadis C, Syed F, Petrova A, Abdul-Wahab A, Lwin SM, Farzaneh F, Chan L, Ghani S, Fleck RA, Glover L, McMillan JR, Chen M, Thrasher AJ, McGrath JA, Di WL, Qasim W.

J Invest Dermatol. 2015 Sep 22. doi: 10.1038/jid.2015.364. [Epub ahead of print]

PMID:
26394110
33.

Ethnicity and craniosynostosis.

Farzaneh F, Moradi E, Habibi Z, Nejat F.

J Neurosurg Pediatr. 2015 Oct;16(4):478-9. doi: 10.3171/2014.12.PEDS14711. Epub 2015 Jul 10. No abstract available.

PMID:
26161717
34.

The combined molecular adjuvant CASAC enhances the CD8+ T cell response to a tumor-associated self-antigen in aged, immunosenescent mice.

Tye GJ, Ioannou K, Amofah E, Quartey-Papafio R, Westrop SJ, Krishnamurthy P, Noble A, Harrison PM, Gaensler KML, Barber LD, Farzaneh F.

Immun Ageing. 2015 Jun 25;12:6. doi: 10.1186/s12979-015-0033-0. eCollection 2015.

36.

Evaluation of the sensitivity and reliability of primary rainbow trout hepatocyte vitellogenin expression as a screening assay for estrogen mimics: Methodological issues.

Sabour S, Farzaneh F, Peymani P.

Aquat Toxicol. 2015 Jul;164:175-6. doi: 10.1016/j.aquatox.2015.05.003. Epub 2015 May 5. No abstract available.

PMID:
26004009
37.

Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma.

Sundarasetty BS, Chan L, Darling D, Giunti G, Farzaneh F, Schenck F, Naundorf S, Kuehlcke K, Ruggiero E, Schmidt M, von Kalle C, Rothe M, Hoon DS, Gerasch L, Figueiredo C, Koehl U, Blasczyk R, Gutzmer R, Stripecke R.

Gene Ther. 2015 Sep;22(9):707-20. doi: 10.1038/gt.2015.43. Epub 2015 May 28.

38.

Evaluation of environmental risk factors for prostate cancer in a population of Iranian patients.

Pouresmaeili F, Hosseini SJ, Farzaneh F, Karimpour A, Azargashb E, Yaghoobi M, Kamarehei M.

Asian Pac J Cancer Prev. 2014;15(24):10603-5.

39.

Active dendritic cell immunotherapy for glioblastoma: Current status and challenges.

Polyzoidis S, Tuazon J, Brazil L, Beaney R, Al-Sarraj ST, Doey L, Logan J, Hurwitz V, Jarosz J, Bhangoo R, Gullan R, Mijovic A, Richardson M, Farzaneh F, Ashkan K.

Br J Neurosurg. 2015 Apr;29(2):197-205. doi: 10.3109/02688697.2014.994473. Epub 2014 Dec 26. Review.

PMID:
25541743
40.

Cerebral abscess complicating embolization of an arteriovenous malformation: Case report and review of litera.

Khoshnevisan A, Ghorbani A, Sistany Allahabadi N, Farzaneh F, Abdollahzadeh S, Soleymani S, Ostovan V.

Iran J Neurol. 2014 Jul 4;13(3):181-4.

41.

Applicability of optical reflectance spectroscopy for detection of precancerous lesions in uterine cervix in vivo.

Hariri Tabrizi S, Farzaneh F, Aghamiri SM.

Arch Iran Med. 2014 Sep;17(9):602-7. doi: 0141709/AIM.004.

42.

Preoperative evaluation of risk of ovarian malignancy algorithm index in prediction of malignancy of adnexal masses.

Farzaneh F, Honarvar Z, Yaraghi M, Yaseri M, Arab M, Hosseini M, Ashrafgangoi T.

Iran Red Crescent Med J. 2014 Jun;16(6):e17185. doi: 10.5812/ircmj.17185. Epub 2014 Jun 5.

43.

Application of tumor markers SCC-Ag, CEA, and TPA in patients with cervical precancerous lesions.

Farzaneh F, Shahghassempour S, Noshine B, Arab M, Yaseri M, Rafizadeh M, Alizadeh K.

Asian Pac J Cancer Prev. 2014;15(9):3911-4.

44.

Women's knowledge and attitude towards mode of delivery and frequency of cesarean section on mother's request in six public and private hospitals in Tehran, Iran, 2012.

Ghotbi F, Akbari Sene A, Azargashb E, Shiva F, Mohtadi M, Zadehmodares S, Farzaneh F, Yasai FA.

J Obstet Gynaecol Res. 2014 May;40(5):1257-66. doi: 10.1111/jog.12335. Epub 2014 Apr 2.

PMID:
24689693
45.

Optimised concentration and purification of retroviruses using membrane chromatography.

McNally DJ, Darling D, Farzaneh F, Levison PR, Slater NK.

J Chromatogr A. 2014 May 2;1340:24-32. doi: 10.1016/j.chroma.2014.03.023. Epub 2014 Mar 15.

46.

Age - specific incidence rate change at breast Cancer and its different histopathologic subtypes in Iran and Western countries.

Hosseini MS, Arab M, Nemati Honar B, Noghabaei G, Safaei N, Ghasemi T, Farzaneh F, Ashraf Ganjoie T.

Pak J Med Sci. 2013 Nov;29(6):1354-7.

47.

Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy.

Oppenheim DE, Spreafico R, Etuk A, Malone D, Amofah E, Peña-Murillo C, Murray T, McLaughlin L, Choi BS, Allan S, Belousov A, Passioukov A, Gerdes C, Umaña P, Farzaneh F, Ross P.

Br J Cancer. 2014 Mar 4;110(5):1221-7. doi: 10.1038/bjc.2014.35. Epub 2014 Feb 4.

48.

Synthesis and characterization of Sr3Al2O6 nanocomposite as catalyst for biodiesel production.

Rashtizadeh E, Farzaneh F, Talebpour Z.

Bioresour Technol. 2014 Feb;154:32-7. doi: 10.1016/j.biortech.2013.12.014. Epub 2013 Dec 12.

PMID:
24384309
49.

Phase I study protocol for ex vivo lentiviral gene therapy for the inherited skin disease, Netherton syndrome.

Di WL, Mellerio JE, Bernadis C, Harper J, Abdul-Wahab A, Ghani S, Chan L, Martinez-Queipo M, Hara H, McNicol AM, Farzaneh F, McGrath J, Thrasher A, Qasim W.

Hum Gene Ther Clin Dev. 2013 Dec;24(4):182-90. doi: 10.1089/humc.2013.195.

PMID:
24329107
50.

Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma.

Delord JP, Tabernero J, García-Carbonero R, Cervantes A, Gomez-Roca C, Bergé Y, Capdevila J, Paz-Ares L, Roda D, Delmar P, Oppenheim D, Brossard SS, Farzaneh F, Manenti L, Passioukov A, Ott MG, Soria JC.

Eur J Cancer. 2014 Feb;50(3):496-505. doi: 10.1016/j.ejca.2013.10.015. Epub 2013 Nov 18.

PMID:
24262587

Supplemental Content

Loading ...
Support Center